Hadron Energy (HDRN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
5 Oct, 2026Executive summary
SPAC had no operating activity or revenue; Q1 income was primarily generated by interest on Trust Account investments while pursuing its announced business combination.
The business combination was expected to close by the end of May 2026, subject to shareholder approval, listing approval, minimum-cash and other conditions.
Financial highlights
Q1 2026 net income was $535,601, down from $1,618,274 in Q1 2025; operating expenses rose to $1,675,288 from $371,833.
Trust Account interest and dividend income was $1,869,218 versus $2,103,979 YoY; fair-value changes in warrant and derivative liabilities also affected results.
Operating cash used was $182,670 in Q1 2026; cash outside the Trust Account ended at $54,692.
Outlook and guidance
Management expected to continue incurring acquisition and public-company costs; operating revenue was not expected before completion of a business combination.
Closing was estimated by the end of May 2026; completion remained conditional on transaction approvals, at least $20 million in available closing SPAC cash and at least $5,000,001 in net tangible assets.
A 21-month business-combination deadline runs from the August 2024 offering; failure to complete by May 30, 2026 would trigger redemption and liquidation procedures unless extended.
Latest events from Hadron Energy
- A $250 million blind-pool IPO pairs a 21-month deadline with steep dilution and conflicts.HDRN
Registration filing - A $250 million SPAC raise pairs a 24-month acquisition search with substantial dilution and conflicts.HDRN
Registration filing - IPO proceeds reached $200.0 million; a business-combination target remains unselected.HDRN
Q3 2024 - Trust interest drove SPAC income as the microreactor target remained loss-making and pre-commercial.HDRN
Q4 2025 - Trust interest lifted Q1 profit as target search and going-concern risks persist.HDRN
Q1 2025 - 25M-unit IPO filing amended solely to add exhibits, with a 3.75M-unit option.HDRN
Registration filing - Trust income drove earnings, but no target and limited operating cash sustain execution risk.HDRN
Q2 2025 - $250M SPAC, no target selected, 24-month deadline and material dilution risks.HDRN
Registration filing - A microreactor commercialization plan meets a large resale overhang and acute funding risk.HDRN
Registration filing